Accuracy of plasma interleukin-6 and C-reactive protein as markers of sepsis in preterm neonates with respiratory distress syndrome by Sarafidis, Kosmas et al.
	 IL-6	and	CRP	in	Septic	Neonates	with	RDS	 17
INTRODUCTION
Neonatal	sepsis	 is	a	 life	 threatening	complication	of	
prematurity	needing	prompt	diagnosis	and	treatment.	
Blood	cultures	are	the	most	specific	tests	for	diagnos-
ing	sepsis.	However,	previous	studies	suggest	that	the	
sensitivity	of	blood	cultures	may	be	low	in	neonates1.	
In	addition,	it	may	take	several	days	to	obtain	a	defi-
nite	answer	for	a	negative	blood	culture.	For	this	rea-
son,	biomarkers	yielding	reliable	results	within	a	few	
hours	are	desirable	in	order	to	support	quick	decisions	
about	 antibiotic	 treatment.	Serum	C-reactive	protein	
(CRP)	is	the	most	widely	used	diagnostic	marker	for	
sepsis	with	a	high	diagnostic	accuracy,	especially	af-
ter	 the	1st	day	of	 the	disease2-9.	During	 recent	years,	
several	 cytokines,	 such	 as	 interleukin-6	 (IL-6)	 and	
interleukin-8	(IL-8)7-10,	and	soluble	receptors	(soluble	
TNF-R,	soluble	IL-2R)	have	been	evaluated	for	early	
detection	of	neonatal	sepsis2-9,11.	IL-6	is	the	most	thor-
oughly	evaluated	sepsis	parameter,	with	a	sensitivity	
up	to	99%	on	first	day	of	neonatal	sepsis4-9,11,12.	
Respiratory	distress	syndrome	(RDS)	is	 the	most	
common	disease	 of	 the	 preterm	neonates	 associated	
with	high	morbidity	and	mortality.	Preterm	neonates	
with	RDS	receiving	intensive	care	may	deteriorate	due	
to	various	complications	either	septic	or	not	 (i.e.	air	
leak	and	patent	ductus	arteriosus).	In	cases	where	no	
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obvious	etiology	can	be	 identified,	clinicians	 should	
be	able	to	assess	if	sepsis	is	the	reason	for	a	clinical	
deterioration.	 �lthough	 surfactant	 deficiency	 is	 the	
main	 cause	 of	RDS	 in	 preterm	neonates,	 a	 growing	
body	of	evidence	suggests	that	inflammatory	response	
is	 involved	 in	 the	pathogenesis	of	 lung	damage	and	
may	influence	the	levels	of	various	immunological	pa-
rameters,	 including	 IL-613,14.	Several	observations	 in	
bronchoalveolar	fluid	point	to	an	important	contribut-
ing	role	of	activated	neutrophils	and	cytokines	in	the	
pathogenesis	of	RDS	and	progression	to	chronic	lung	
disease14,15.	 In	 neonates	 with	 RDS	 elevated	 concen-
trations	of	IL-6	have	been	found	in	the	plasma16	and	
tracheobronchial	lavage	early	in	the	course	of	the	dis-
ease17.	Moreover,	elevation	of	IL-6	and	IL-8	precedes	
the	 influx	 of	 neutrophils	 in	 the	 bronchial	 secretions	
of	preterm	infants	with	RDS	who	progress	to	chronic	
lung	disease18.	Based	on	these	data,	we	assumed	that	
plasma	IL-6	levels	may	not	be	an	accurate	predictor	of	
septic	complications	in	neonates	suffering	from	RDS.	
In	this	study	IL-6	and	CRP	levels	were	measured	
in	preterm	neonates	with	and	without	RDS	who	de-
veloped	clinical	signs	suggestive	of	sepsis	aiming	at	
evaluating	 the	accuracy	of	 these	 two	markers	 in	de-
tecting	sepsis	and	how	it	is	influenced	by	the	presence	
of	RDS.	
PATIeNTS AND meThODS
Study population
In	a	prospective	study,	140	preterm	neonates,	62	with	
RDS	and	78	without	RDS,	who	were	hospitalized	in	
the	1st	Neonatal	Department	of	 the	�ristotle	Univer-
sity	of	Thessaloniki	and	developed	clinical	evidence	
of	 sepsis	were	 included.	Clinical	 signs	 of	 suspected	
sepsis	were	lethargy,	hypotonia,	reduced	motor	activ-
ity,	pallor,	hypotension,	decreased	peripheral	circula-
tion,	 deterioration	 of	 respiratory	 distress,	 increasing	
demands	for	ventilatory	support,	feeding	intolerance,	
abdominal	 distension,	 vomiting	 and	 bloody	 gastric	
aspirates	 or	 stools.	 Diagnosis	 of	 RDS	was	made	 in	
neonates	 with	 respiratory	 distress	 and	 radiological	
findings	consistent	with	RDS. Neonates	with	positive	
blood	cultures	were	defined	as	septic.	The	study	was	
approved	by	the	ethical	committee	of	our	institution.	
Blood	samples	were	collected	as	soon	as	clinical	signs	
of	sepsis	emerged.	
Laboratory investigation
Laboratory	investigation	included	a	full	sepsis	screen	
(complete	blood	count	and	differential,	platelet	count	
and	CRP	measurement),	measurement	of	plasma	IL-6	
and	blood	and	urine	cultures	 for	bacteria	 and	 fungi.	
Chest	radiographs	were	routinely	performed	while	ce-
rebrospinal	fluid	cultures	and	abdominal	radiographs	
were	performed	when	clinically	 indicated. CRP	was	
measured	by	using	nephelometry.	IL-6	was	measured	
by	 a	 solid	 phase	 quantitative	 enzyme	 immunoassay	
with	 appropriate	 commercial	 available	 kits	 (Quanti-
kine-R&D	 systems,	 British	 Biotechnology,	 Ltd)	 ac-
cording	to	the	manufacturer’s	instructions.	The	lower	
limit	of	detection	was	0.36	pg/mL	and	3.5	mg/L	for	
IL-6	and	CRP,	respectively.
Statistical analysis
�alues	 of	 IL-6	 and	CRP	were	 not	 normally	 distrib-
uted	(Kolmogorov-Smirnov	test)	and	differences	be-
tween	groups	were	analyzed	using	the	Mann	Whitney	
U-test.	Comparisons	 of	 dichotomous	 variables	were	
performed	 using	 the	 Fisher	 exact	 test.	�	 two-sided	
significant	level	of	0,05	or	less	was	considered	statis-
tically	significant.
To	 test	 the	 validity	 of	 these	markers	 in	 diagnos-
ing	sepsis	two	receiver	operating	characteristic	(ROC)	
curves	were	obtained	for	IL-6	and	CRP,	each	one	in	
the	RDS	and	the	non	RDS	groups.	The	area	under	the	
curve	(�UC)	was	used	as	an	estimator	of	the	overall	
diagnostic	 accuracy19.	 Sensitivity,	 specificity,	 posi-
tive	predictive	value	(PP�),	negative	predictive	value	
(NP�)	 and	 the	 likelihood	 ratios	 (LR)	 for	 detecting	
sepsis	were	calculated	for	CRP	using	the	level	of	10	
mg/L	 as	 cut-off	 value20	 and	 for	 IL-6	 using	 two	 dif-
ferent	cut-off	values,	the	20	pm/mL	and	the	80	pg/ml	
based	on	published	data3,20-22.	Statistical	analyses	were	
performed	using	 the	 softwares	SPSS	16.0	 for	WIN-
DOWS®	και	�raphPad	InStat	3®.	
ReSUlTS
Population characteristics 
Blood	cultures	were	found	positive	in	64	neonates	(37	
with	RDS	and	27	without	RDS)	and	negative	in	76	(25	
with	RDS	and	51	without	RDS)	 (Table	1).	The	 two	
groups	of	neonates	with	RDS	(septic	and	non-septic)	
did	not	differ	significantly	with	regard	to	the	clinical	
characteristics	 and	 the	 incidence	 of	 the	 commonest	
neonatal	problems.	�lso,	similar	numbers	among	the	
two	groups	were	on	mechanical	ventilation,	on	 total	
parenteral	nutrition	and	presence	of	umbilical	arterial	
catheters.	Comparison	between	the	two	groups	of	ne-
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onates	without	RDS	showed	that	the	septic	neonates	
had	a	higher	��	of	borderline	significance,	obviously	
due	to	the	fact	that	in	the	absence	of	RDS,	sepsis	is	the	
main	reason	of	clinical	deterioration	of	preterm	neo-
nates	with	higher	��.	�lso,	septic	neonates	without	
RDS	had	significantly	higher	incidence	of	necrotizing	
enterocolitis,	ventilatory	support	and	total	parenteral	
nutrition	in	comparison	with	the	non-septic-non-RDS	
neonates,	 as	 expected	 (Table	 1).	 Microorganisms	
isolated	from	blood	cultures	 included	klebsiella	spp.	
(n	 =	 23),	 coagulase negative staphylococcus	 spp.	
(n	=	17),	coagulase positive staphylococcus	 (n	=	5),	
fungi	 (n	 =	 5),	 streptococcus spp	 (n	 =	 2),	 acineto-
bacter	(n	=	5),	enterobacter	(n	=	3),	pseudomonas spp	
(n	=	2),	E. Coli	(n	=	1)	and	enterococcus	(n	=	1).
Plasma IL-6 levels
�mong	the	neonates	without	RDS,	those	with	sepsis	
had	significantly	higher	IL-6	levels	than	the	non-septic	
ones.	In	neonates	with	RDS,	IL-6	levels	did	not	differ	
significantly	between	the	septic	and	non-septic	ones.	
Comparison	 between	 the	 two	 groups	without	 sepsis	
showed	neonates	with	RDS	had	 significantly	higher	
IL-6	than	those	without	RDS	(p	<	0,0001).	No	signifi-
cant	difference	was	found	between	the	two	groups	of	
septic	neonates	(p	=	0,25)	(Table	2).
Serum CRP levels
�mong	the	two	groups	without	RDS,	those	with	sep-
sis	had	significantly	higher	CRP	levels	in	comparison	
with	 neonates	without	 sepsis.	 Similarly,	 οf	 the	 neo-
nates	with	RDS,	neonates	with	sepsis	had	significant-
ly	higher	CRP	levels	than	those	without	sepsis	(Table	
Table 1. Clinical	of	the	studied	population.
NeONATeS WITh RDS NeONATeS WIThOUT RDS
�ROUPS NON-	S�PTIC	 S�PTIC p	 NON-S�PTIC	 S�PTIC	 p	
n 25 37 51 27
�estational	age	(wks,	
x�SD, range)	
30,1	� 3,3	 	
(25-37)
30,8	� 2,4	
(27-37)
0,39 31,5	� 2,7	
(26-36)
32,2	� 3,2	
(26-37)
0,044
Birth	weight	(g,	
x�SD, range)	
1434	� 511	
(650-2700)
1546	� 490	
(800-2820)
0,43 1703	� 512	
(850-2940)
1718	� 636	
(720-2730)
0,91
�ge	at	study	entry	(d) 5,0	� 5,2	
(1-21)
7,6	� 5,0	
(0-24)
0,075 5,3	� 6,7	
(0-28)
7,8	� 5,0	
(1-22)
0,65
sex	(M/F) 17/8 23/14 0,79 29/22 13/14 0,16
Perinatal	asphyxia	
(n,	%)
3	(12) 5	(14) 1 8	(16) 3	(11) 0,74
Mechanical	
ventilation	(n,	%)
18	(72) 35	(95) 0,21 21	(41) 19	(70) 0,018
Umbilical	arterial	
catheter	(n,	%)
23	(92) 35	(95) 1 9	(18) 7	(26) 0,39
Patent	ductus	
arteriosous	(n,	%)
2	(8) 7	(19) 0,29 - 1	(4) 0,42
Necrotizing	
enterocolitis	(n,	%)
- 3	(8) 0,266 - 3	(11) 0,07
Intra-peri-ventricular
haemorrhage	grade
III-I�	(n,	%)
3	(12) 6	(16) 0,73 - - N.S.
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2).	No	significant	difference	was	 found	between	 the	
two	groups	of	non-septic	neonates	(with	and	without	
RDS)	nor	between	the	two	groups	of	septic	ones.	
Diagnostic accuracy
The	 ROC	 curves	 obtained	 from	 the	 neonates	 with-
out	RDS	showed	that	both	markers	were	accurate	in	
diagnosing	 sepsis	 in	 this	 group	 of	 neonates	with	 an	
�UC	of	0,914	and	0,863	 for	 IL-6	and	CRP,	 respec-
tively	(Figure	1).	However,	the	ROC	curves	obtained	
from	neonates	with	RDS	showed	that	the	IL-6	had	a	
low	overall	accuracy	with	an	�UC	0,642	(30%	lower	
than	that	in	the	non-RDS	group),	whereas	the	overall	
accuracy	CRP	remained	high	with	an	�UC	0,808	(fig.	
2).	The	sensitivity,	specificity,	PP�,	NP�	and	LR	of	
IL-6	>20	pg/mL	and	>80	pg/mL	and	CRP	>10mg/L	in	
neonates	with	RDS	and	those	without	RDS	are	shown	
in	Tables	3	and	4.	
DISCUSSION
The	main	findings	of	 our	 study	were	 two;	 a)	 In	ne-
onates	without	RDS	both	 the	 IL-6	 and	CRP	are	 ac-
curate	 diagnostic	 markers	 of	 blood	 culture	 proven	
sepsis,	whereas	in	those	with	RDS	IL-6	is	of	limited	
diagnostic	value	and	only	 the	CRP	can	be	used	as	a	
marker	of	sepsis.	b)	In	neonates	with	RDS	IL-6	levels	
are	increased	regardless	of	the	presence	of	sepsis.	
Previous	 studies	 have	 documented	 increased	 cir-
culating	IL-6	levels	soon	after	the	onset	of	sepsis.	For	
his	 reason,	 this	 proinflammatory	 cytokine	 has	 been	
evaluated	as	a	diagnostic	tool	by	several	authors7,9,20,23.	
The	reported	sensitivity	of	IL-6	in	detecting	neonatal	
sepsis	ranges	from	0,80	to	1,00,	 the	specificity	from	
0,43	 to	 1,00	 and	 the	 positive	LR	 from	1,5	 to	 21,53-
9,11,16,24.	These	discrepancies,	which	make	the	compari-
sons	between	studies	difficult,	can	be	attributed	to	the	
Table 2.	Plasma	IL-6	and	serum	CRP	levels	in	the	groups	studied.
�ROUPS
NeONATeS WITh RDS NeONATeS WIThOUT RDS
NON-	
S�PTIC	
S�PTIC	 p NON- S�PTIC	 	 S�PTIC	 p
n 25 37 51 27
IL-6	(pg/mL,	median-	
range)
129	
(13-480)
326		
(12-480)
0,059 10,0		
(1-372)
305		
(3-480)
<	0,0001
CRP
(mg/L,	median-range)
3,5		
(3,5-99)
23		
(3,5-150)
<	0,0001 3,5	(3,5-45) 44	(3,5-132) <	0,0001
Figure 1.	The	ROC	curves	for	CRP	and	IL-6	in	neonates	
without	RDS	and	those	without	RDS.
Figure 2.	The	ROC	curves	for	CRP	and	IL-6	in	neonates	
without	RDS	and	those	with	RDS.
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wide	range	of	cut-off	points	used	(15	pg/mL	-	150	pg/
mL),	the	demographic	data	of	the	population	studied	
and	the	time	elapsed	between	the	onset	of	sepsis	and	
blood	sampling25,26.	In	most	studies,	the	cut-off	values	
used	were	obtained	from	healthy	neonates.	However,	
for	a	certain	population,	like	neonates	with	RDS,	spe-
cial	cut-off	values	may	be	needed.	In	our	study,	two	
ROC	curves	were	evaluated;	the	first,	for	the	neonates	
without	RDS	and	the	second,	for	those	with	RDS.	The	
ROC	curve	obtained	from	neonates	without	RDS	had	
an	�UC	of	0,901	which	is	considered	high	for	a	diag-
nostic	test.	However,	when	values	from	neonates	with	
RDS	were	 used	 for	ROC	curve,	 the	�UC	was	 very	
low	(0,642)	indicating	that	IL-6	has	a	low	overall	ac-
curacy	in	diagnosing	sepsis	in	this	group	of	neonates.
Further	 analysis	 showed	 that	 in	 neonates	 with-
out	RDS	the	IL-6	≥	20	pg/mL	had	a	high	sensitivity	
(0,93),	which	is	very	important	when	dealing	with	a	
disease	like	neonatal	sepsis	that	could	be	fatal	without	
prompt	treatment.	Ideally,	the	specificity	should	also	
be	high	in	order	to	avoid	a	high	rate	of	false	positive	
results	leading	to	unnecessary	use	of	antibiotics.	Un-
fortunately,	in	our	study	the	IL-6	>	20pg/mL	had	a	low	
specificity	(0,65).	In	addition,	the	LR	of	2,68	is	rather	
weakly	positive	 for	 the	 disease,	 implying	 that,	 even	
in	the	absence	of	RDS,	a	neonate	with	sepsis	is	only	
about	2,5	times	more	likely	to	have	an	IL-6	over	20	
than	a	non-septic	one27,28.	
Neonates	suffering	from	RDS	form	a	very	specific	
group	 of	 preterm	 neonates,	 where	 inflammatory	 re-
sponse	is	involved	in	the	pathogenesis	and	progression	
to	chronic	lung	disease13,14,16,18.	This	view	is	supported	
by	the	high	plasma	IL-6	levels	in	neonates	with	RDS	
found	 in	our	study.	This	finding	also	suggests	 that	a	
cut-off	value	of	IL-6	based	on	values	obtained	from	
neonates	without	RDS	as	referent	population	may	not	
be	suitable	for	detecting	septic	complications	in	neo-
nates	with	RDS.	Indeed,	 in	our	study,	 the	use	of	 the	
Table 3.	Diagnostic	accuracy	of	plasma	IL-6	and	serum	CRP	in	neonates	without	RDS.
Il-6 ≥ 20 pg/ml Il-6 ≥ 80 pg/ml CRP ≥ 10 mg/l
�alue	(96%	CI) �alue	(96%	CI) �alue	(96%	CI)
Sensitivity 0,93	(0,77-0,99) 0,71	(0,51-0,87) 0,86	(0,67-0,96)
Specificity 0,65	(0,51-0,78) 0,94	(0,84-0,99) 0,71	(0,57-0,83)
PPV 0,59	(0,43-0,74) 0,87	(0,66-0,97) 0,62	(0,45-0,77)
NPV 0,94	(0.81-0,99) 0,86	(0,74-0,94) 0,90	(0,77-0,97)
lR 2,68 12,38 2,97
PPV: Positive Predictive Value, NPV: Negative Predictive Value, LR: Likelihood Ratio.
Table 4.	Diagnostic	accuracy	of	plasma	IL-6	and	serum	CRP	in	neonates	with	RDS.
Il-6 >18 pg/ml Il-6>80 pg/ml CRP>10 mg/l
�alue	(95%	CI) �alue	(95%	CI) �alue	(95%	CI)
Sensitivity 0,92	(0,78-0,98) 0,81	(0,65-0,92) 0,73	(0,56-0,86)
Specificity 0,16	(0,05-0,36) 0,40	(0,21-0,61) 0,68	(0,46-0,85)
PPV 0,62	(0,48-0,75) 0,67	(0,51-0,80) 0,77	(0,60-0,90)
NPV 0,57	(0,18-0,90) 0,59	(0,33-0,82) 0,63	(0,42-0,81)
lR 1,09 1,35 2,28
PPV: Positive Predictive Value, NPV: Negative Predictive Value, LR: Likelihood Ratio.
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level	20	pg/mL	as	cut-off	value	for	the	RDS	group	re-
sulted	in	a	high	sensitivity	(0,92)	but	a	very	low	speci-
ficity	(0,16).	These	figures	imply	that	in	neonates	with	
RDS	a	level	of	IL-6	>	20	pg/mL	can	accurately	detect	
sepsis	 in	92%	of	 the	cases,	which	 is	acceptable,	but	
it	has	a	high	rate	of	false	positive	results.	In	addition,	
the	extremely	low	LR	found	in	this	group	of	sick	neo-
nates	(1,09)	implies	that	IL-6	levels	over	20	pg/mL	are	
found	equally	in	both	septic	and	non-septic	neonates	
with	RDS29.	In	line	with	these	results,	Kallman	et	al16	
reported	that	measurement	of	IL-6	could	not	discrimi-
nate	between	septic	neonates	and	those	with	RDS.	For	
this	reason,	in	the	RDS	group,	we	assessed	the	diag-
nostic	accuracy	of	a	higher	IL-6	level,	namely	the	lev-
el	of	80	pg/mL	which	has	been	suggested	by	previous	
researchers3,20-22.	The	use	of	the	IL-6	of	80	pg/mL	as	
a	cut-off	value	for	the	neonates	with	RDS	resulted	in	
lower	sensitivity	and	a	better,	albeit	still	unacceptably	
low,	specificity	(0,40).	The	LR	was	also	low	(1,35)	as	
was	the	NP�	(0,59).	From	the	clinical	point	of	view	
these	figures	would	not	 justify	withholding	or	with-
drawing	treatment	when	neonatal	sepsis	is	suspected	
only	on	the	grounds	of	an	IL-6	<	80	pg/mL.	
Unlike	 IL-6,	 CRP	 levels	were	 not	 influenced	 by	
the	presence	of	RDS	and	 thus	did	not	differ	 signifi-
cantly	between	neonates	with	RDS	and	those	without	
RDS.	On	the	other	hand,	CRP	levels	were	significant-
ly	increased	in	the	septic	neonates	as	compared	to	the	
non-septic	ones,	 regardless	of	 the	presence	of	RDS.	
�stimation	of	diagnostic	accuracy	of	CRP	by	the	ROC	
curves	showed	that	the	�UC	was	not	influenced	by	the	
presence	of	RDS	being	high	in	both	the	non	RDS	and	
RDS	 groups	 (0,863	 and	 0,808,	 respectively).	When	
the	overall	diagnostic	accuracy	of	IL-6	and	CRP	were	
compared,	in	neonates	without	RDS	both	parameters	
had	a	similar	�UC,	whereas	in	neonates	with	RDS	the	
CRP	had	higher	�UC	than	the	IL-6	(0,808	vs.	0,642).	
The	accuracy	of	CRP	as	a	marker	of	neonatal	sepsis	
has	 been	 well-documented	 in	 previous	 studies,	 al-
though	there	is	still	a	controversy	as	to	whether	CRP	
is	 a	 better	 predictor	 of	 neonatal	 sepsis	 than	 IL-64-9.	
However,	most	authors	support	the	view	that	IL-6	is	
a	 better	 predictor	 during	 the	 first	 24	 hours	 after	 the	
onset	of	 sepsis,	whereas	CRP	seems	 to	be	more	ac-
curate	after	this	time6,20.	Nevertheless,	the	time	of	the	
onset	of	sepsis	can	not	always	be	accurately	defined.	
In	our	 study,	blood	 samples	were	obtain	at	 the	 time	
of	clinical	deterioration,	but	still	this	time	point	does	
not	necessarily	coincide	with	the	onset	of	sepsis.	Our	
results	showed	that	CRP	had	a	lower	sensitivity	than	
that	of	IL-6	at	either	>	20	pg/mL	or	>	80	pg/mL,	but	a	
higher	specificity.	The	LRs	of	CRP	(2,97)	in	neonates	
without	RDS	was	similar	to	that	of	IL-6	>	20	(2,68)	
but	 lower	 than	 the	LR	of	 IL-6	>	80	pg/mL	 (12,38).	
However,	in	neonates	with	RDS	the	LR	of	CRP	was	
higher	than	that	of	IL-6	at	both	levels.
In	conclusion,	 in	neonates	without	RDS	both	 the	
IL-6	and	CRP	are	acceptably	accurate	 in	diagnosing	
sepsis,	whereas	in	those	with	RDS	the	diagnostic	val-
ue	of	IL-6	is	 limited.	The	high	sensitivity	of	plasma	
IL-6	at	 levels	over	20	pg/mL	 in	neonates	with	RDS	
could	be	useful	for	ruling	out	sepsis,	but	the	low	LR	
limits	its	usefulness	as	a	diagnostic	tool.	
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